Evaluation of serum PSA in brain-dead subjects over the age of 50 before organ harvesting: Organ donation and the risk of transmission of prostate cancer. Survey of the transplantation committee of the Association Francaise d'Urologie;Evaluation du taux de PSA sérique des sujets en état de mort encéphalique de plus de 50 ans avant prélèvement d'organes: Risque de transmission du cancer de prostate et don d'organes. Enquête des comités de transplantation et de cancérologie de l'Association française d'Urologie

Progres en Urologie

Volumn 17, Issue 4, 2007, Pages 828-831

  Salomon, Laurent ^a   Feuillu, Benoit ^b   Petit, Jacques ^c   Sallusto, Frederico ^d   Lechevallier, Eric ^e   Eschwege, Pascal ^f  

^a HENRI MONDOR HOSPITAL   (France)

^b Service Urologie   (France)

^c AMIENS UNIVERSITY HOSPITAL   (France)

^d CHU RANGUEIL   (France)

^e Child and Adolescent Psychopathology Unit Salvator Hospital Public Assistance Marseille Hospitals University Aix Marseille II   (France)

^f BICÊTRE HOSPITAL   (France)

Author keywords

Cancer; Prostate; Transplantation

Indexed keywords

EID: 34547212817     PISSN: 11667087     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1166-7087(07)92301-5     Document Type: Article

References (20)

1. CONLON P.J., SMITH S.R. : Transmission of cancer with cadaveric donor organs, J. Am. Soc. Nephrol., 1995 ; 6 : 54-60.
2. SHEIL A.G. : Donor-derived malignancy in organ transplant recipients. Transplant. Proc., 2001 ; 33 : 1827-1829.
3. KAUFFMAN H.M., MCBRIDE M.A., CHERIKH W.S., ET AL. : Transplant tumor registry : donor related malignancies. Transplantation, 2002 ; 74 : 358.
4. FENG S., BUELL J.F., CHERIKH W.S., DENG M.C., HANTO D.W., KAUFFMAN H.M., LEICHTMAN A.B., LORBER M.I., MATERS R.G., MCBRIDE M.A., METZGER R.A., NOLTE F.S., O'CONNOR K.J., ROTH D., TERRAULT N.A., HENRY M.L. : Organs donors with positive viral serology or malignancy : risk of disease transmission by transplantation. Transplantation 2002 ; 74 : 1657-1663.
5. AGENCE DE BIOMEDECINE : Bilan des activités de prélèvement et de greffe en France, http://www.agence-biomedecine. fr/fr/doc/rapp-synth2005.pdf
6. KAUFFMAN H.M., MCBRIDE M.A., DELMONICO F.L. : First report of the United Network for Organ Sharing Transplant Tumor Registry : donors with a history of cancer. Transplantation, 2000 ; 70 : 1747.
7. MICHELI A., MUGNO E., KROGH V., QUINN M.J., COLEMAN M., HAKULINEN T., GATTA G., BERRINO F., CAPOCACCIA R., EUROPREVAL WORKING GROUP : Cancer prevalence in European registry areas. Ann. Oncol., 2002 ; 13 : 815-816.
8. COMITÉ DE CANCÉROLOGIE DE L'ASSOCIATION FRANÇAISE D'UROLOGIE. Recommandations 2004 en Onco-Urologie. Prog. Urol., 2004 ; 14 : 919.
9. BIRKELAND S.A., STORM H.H. : Risk for tumor and other disease transmission by transplantation : a population based study of unrecognised malignancies and other disease in organ donors. Transplantation, 2002 ; 74 : 1409.
10. BUELL J.F., TROFE J., HANAWAY M.J., LO A., ROSENGARD B., RILO H., ALLOWAY R., BEEBE T., FIRST M.R., WOODLE E.S. : Transmission of donor cancer into cardiothoracic transplant recipients. Surgery, 2001 ; 130:660-668.
11. SEIDMAN H., MUSHINSKI M.H., GELB S.K., SILVERBERG E. : Probabilities of eventually developing or dying of cancer. CA Cancer J, Clin., 1985 ; 35 : 36-56.
12. HSING A.W., TSAO L., DEVESA S.S. : International trends and patterns of prostate cancer incidence and mortality. Int. J. Cancer, 2000 ; 85 : 60-67.
13. WANG M.C., VALENZUELA L.A., MURPHY G.P., CHU T.M. : Purification of a human prostatic specific antigen Invest. Urol., 1979 ; 17 : 159-163.
14. KHAN M.A., PARTIN A.W, RITTENHOUSE H.G., MIKOLAJCZYK S.D., SOKOLL L.J., CHAN D.W., VELTRI R.W. : Evaluation of prostate specific antigen for early detection of prostate cancer in men with a total prostate specific antigen range of 4.0 to 10.0 ng/ml. J. Urol., 2003 ; 170 : 723-726.
15. LOH E., COUCH F.J., HENDRICKSEN C., FARID L., KELLY P.F., ACKER M.A., TOMASZEWSKI J.E., MALKOWICZ S.B., WEBER B.L.: Development of donor-derived prostate cancer in a recipient following orthotopic heart transplantation. JAMA, 1997 ; 227 : 133-137.
16. LIOTTA L.A., KLEINERMAN J., SAIDEL G.M. : Quantitative relationships of intravascular tumor cells, tumor vessels, and pulmonary metastases following tumor implantation. Cancer Res., 1974 ; 5 : 997-1004.
17. WALZ P.H., SCHOPPMANN T., BUSCHER C., ENNEN J., SCHRIEWER H. : Influence of prostatic disease and prostatic manipulations on the concentration of prostate-specific antigen. Eur. Urol., 1992 ; 2220-2226.
18. MATZKTN H., LAUFER M., CHEN J., HAREUVENIM., BRAF Z. : Effect of elective prolonged urethral catheterization on serum prostate-specific antigen concentration. Urology, 1996 ; 48 : 63-66.
19. BATISLAM E., ARIK A.I., KARAKOC A., UYGUR M.C., GERMIYANOGLU R.C., EROL D. : Effect of transurethral indwelling catheter on serum prostate-specific antigen level in benign prostatic hyperplasia. Urology, 1997;49:50-54.
20. FRUTOS M.A., DAGA D., RUIZ P., MANSILIA J.J., REQUENA M.V. : Prostate-Specific Antigen in the assesment of organ donors. Transplant Proc. 2003 ; 35 : 1644-1646.